276 related articles for article (PubMed ID: 31040191)
21. Multiple rounds of one sample versus two sample faecal immunochemical test-based colorectal cancer screening: a population-based study.
Schreuders EH; Grobbee EJ; Nieuwenburg SAV; Kapidzic A; van Roon AHC; van Vuuren AJ; Lansdorp-Vogelaar I; Spijker WWJ; Izelaar K; Bruno MJ; Kuipers EJ; Spaander MCW
Lancet Gastroenterol Hepatol; 2019 Aug; 4(8):622-631. PubMed ID: 31196734
[TBL] [Abstract][Full Text] [Related]
22. Association of time to colonoscopy after a positive fecal test result and fecal hemoglobin concentration with risk of advanced colorectal neoplasia.
Kim NH; Lim JW; Kim S; Lim JY; Kim W; Park JH; Park DI; Sohn CI; Jung YS
Dig Liver Dis; 2019 Apr; 51(4):589-594. PubMed ID: 30733186
[TBL] [Abstract][Full Text] [Related]
23. Impact of the COVID-19 Pandemic on Fecal Immunochemical Testing, Colonoscopy Services, and Colorectal Neoplasia Detection in a Large United States Community-based Population.
Lee JK; Lam AY; Jensen CD; Marks AR; Badalov J; Layefsky E; Kao K; Ho NJ; Schottinger JE; Ghai NR; Carlson CM; Halm EA; Green B; Li D; Corley DA; Levin TR
Gastroenterology; 2022 Sep; 163(3):723-731.e6. PubMed ID: 35580655
[TBL] [Abstract][Full Text] [Related]
24. Effects of Increasing Screening Age and Fecal Hemoglobin Cutoff Concentrations in a Colorectal Cancer Screening Program.
Wieten E; Schreuders EH; Nieuwenburg SA; Hansen BE; Lansdorp-Vogelaar I; Kuipers EJ; Bruno MJ; Spaander MC
Clin Gastroenterol Hepatol; 2016 Dec; 14(12):1771-1777. PubMed ID: 27567693
[TBL] [Abstract][Full Text] [Related]
25. Quality of colonoscopy in an organised colorectal cancer screening programme with immunochemical faecal occult blood test: the EQuIPE study (Evaluating Quality Indicators of the Performance of Endoscopy).
Zorzi M; Senore C; Da Re F; Barca A; Bonelli LA; Cannizzaro R; Fasoli R; Di Furia L; Di Giulio E; Mantellini P; Naldoni C; Sassatelli R; Rex D; Hassan C; Zappa M;
Gut; 2015 Sep; 64(9):1389-96. PubMed ID: 25227521
[TBL] [Abstract][Full Text] [Related]
26. Equivalency of fecal immunochemical tests and colonoscopy in familial colorectal cancer screening.
Quintero E; Carrillo M; Gimeno-García AZ; Hernández-Guerra M; Nicolás-Pérez D; Alonso-Abreu I; Díez-Fuentes ML; Abraira V
Gastroenterology; 2014 Nov; 147(5):1021-30.e1; quiz e16-7. PubMed ID: 25127679
[TBL] [Abstract][Full Text] [Related]
27. Changes in FIT values below the threshold of positivity and short-term risk of advanced colorectal neoplasia: Results from a population-based cancer screening program.
Buron A; Román M; Augé JM; Macià F; Grau J; Sala M; Louro J; Martinez-Alonso M; Alvarez-Urturi C; Andreu M; Bessa X; Zaffalon D; Castells A; Pellisé M; Aldea M; Rivero L; Hernández C; Torá-Rocamora I; Castells X
Eur J Cancer; 2019 Jan; 107():53-59. PubMed ID: 30544059
[TBL] [Abstract][Full Text] [Related]
28. Consequences of Increasing Time to Colonoscopy Examination After Positive Result From Fecal Colorectal Cancer Screening Test.
Meester RG; Zauber AG; Doubeni CA; Jensen CD; Quinn VP; Helfand M; Dominitz JA; Levin TR; Corley DA; Lansdorp-Vogelaar I
Clin Gastroenterol Hepatol; 2016 Oct; 14(10):1445-1451.e8. PubMed ID: 27211498
[TBL] [Abstract][Full Text] [Related]
29. Fecal immunochemical testing results and characteristics of colonic lesions.
van Doorn SC; Stegeman I; Stroobants AK; Mundt MW; de Wijkerslooth TR; Fockens P; Kuipers EJ; Bossuyt PM; Dekker E
Endoscopy; 2015 Nov; 47(11):1011-7. PubMed ID: 26126163
[TBL] [Abstract][Full Text] [Related]
30. Performance of the Asia-Pacific Colorectal Screening score in stratifying the risk of advanced colorectal neoplasia: A meta-analysis and systematic review.
Luu MN; Trinh NA; Tran TLT; Dang TP; Hiyama T; Quach DT
J Gastroenterol Hepatol; 2024 Jun; 39(6):1000-1007. PubMed ID: 38425009
[TBL] [Abstract][Full Text] [Related]
31. Comparison of a New-generation Fecal Immunochemical Test (FIT) With Guaiac Fecal Occult Blood Test (gFOBT) in Detecting Colorectal Neoplasia Among Colonoscopy-referral Patients.
Guimarães DP; Fregnani JH; Reis RM; Taveira LN; Scapulatempo-Neto C; Matsushita M; Silva SRM; Oliveira CZ; Longatto-Filho A; Eklund C; Paloheimo L; Mauad E; Suovaniemi O; Syrjänen K
Anticancer Res; 2019 Jan; 39(1):261-269. PubMed ID: 30591467
[TBL] [Abstract][Full Text] [Related]
32. A comparison of the immunochemical fecal occult blood test and total colonoscopy in the asymptomatic population.
Morikawa T; Kato J; Yamaji Y; Wada R; Mitsushima T; Shiratori Y
Gastroenterology; 2005 Aug; 129(2):422-8. PubMed ID: 16083699
[TBL] [Abstract][Full Text] [Related]
33. Contribution of patient, physician, and environmental factors to demographic and health variation in colonoscopy follow-up for abnormal colorectal cancer screening test results.
Partin MR; Gravely AA; Burgess JF; Haggstrom DA; Lillie SE; Nelson DB; Nugent SM; Shaukat A; Sultan S; Walter LC; Burgess DJ
Cancer; 2017 Sep; 123(18):3502-3512. PubMed ID: 28493543
[TBL] [Abstract][Full Text] [Related]
34. A Risk-Scoring System Combined With a Fecal Immunochemical Test Is Effective in Screening High-Risk Subjects for Early Colonoscopy to Detect Advanced Colorectal Neoplasms.
Chiu HM; Ching JY; Wu KC; Rerknimitr R; Li J; Wu DC; Goh KL; Matsuda T; Kim HS; Leong R; Yeoh KG; Chong VH; Sollano JD; Ahmed F; Menon J; Sung JJ;
Gastroenterology; 2016 Mar; 150(3):617-625.e3. PubMed ID: 26627608
[TBL] [Abstract][Full Text] [Related]
35. Colorectal cancer screening with fecal immunochemical testing: a community-based, cross-sectional study in average-risk individuals in Nigeria.
Alatise OI; Dare AJ; Akinyemi PA; Abdulkareem FB; Olatoke SA; Knapp GC; Kingham TP;
Lancet Glob Health; 2022 Jul; 10(7):e1012-e1022. PubMed ID: 35714629
[TBL] [Abstract][Full Text] [Related]
36. Participant-Related Risk Factors for False-Positive and False-Negative Fecal Immunochemical Tests in Colorectal Cancer Screening: Systematic Review and Meta-Analysis.
de Klerk CM; Vendrig LM; Bossuyt PM; Dekker E
Am J Gastroenterol; 2018 Dec; 113(12):1778-1787. PubMed ID: 30158713
[TBL] [Abstract][Full Text] [Related]
37. Quality Metrics of a Fecal Immunochemical Test-Based Colorectal Cancer Screening Program in Korea.
Kim DH; Cha JM; Kwak MS; Yoon JY; Cho YH; Jeon JW; Shin HP; Joo KR; Lee JI
Gut Liver; 2018 Mar; 12(2):183-189. PubMed ID: 29212310
[TBL] [Abstract][Full Text] [Related]
38. Outreach invitations for FIT and colonoscopy improve colorectal cancer screening rates: A randomized controlled trial in a safety-net health system.
Singal AG; Gupta S; Tiro JA; Skinner CS; McCallister K; Sanders JM; Bishop WP; Agrawal D; Mayorga CA; Ahn C; Loewen AC; Santini NO; Halm EA
Cancer; 2016 Feb; 122(3):456-63. PubMed ID: 26535565
[TBL] [Abstract][Full Text] [Related]
39. Identifying the optimal strategy for screening of advanced colorectal neoplasia.
Jung YS; Park CH; Kim NH; Park JH; Park DI; Sohn CI
J Gastroenterol Hepatol; 2017 May; 32(5):1003-1010. PubMed ID: 28449340
[TBL] [Abstract][Full Text] [Related]
40. The fecal immunochemical test has high accuracy for detecting advanced colorectal neoplasia before age 50.
Kim NH; Park JH; Park DI; Sohn CI; Choi K; Jung YS
Dig Liver Dis; 2017 May; 49(5):557-561. PubMed ID: 28065631
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
